4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-17-030593
CIK 0001505512operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:25 PM ET
Size
5.4 KB
Accession
0001209191-17-030593
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-05-04+350,000→ 350,000 totalExercise: $1.70Exp: 2027-05-03→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on May 4, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on May 4, 2021.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:25 PM ET
- Size
- 5.4 KB